Venus Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies Limited has submitted its financial results to the NSE for the quarter/half-year ended September 30, 2025. The announcement only confirms the submission of results and does not include the actual financial figures, key metrics, or auditor observations in the headline. Retail investors would need to refer to the detailed results document to evaluate performance. No specific revenue, profit, or margin numbers are disclosed in this filing notice.
This is a routine regulatory filing confirming compliance with listing requirements; it does not by itself indicate any positive or negative development for shareholders. The actual stock impact will depend on the numbers inside the results document, which are not summarised here.